Skip to main content
Caplight Logo









Arontier

Arontier

Private
SeoulHealthcare & Life Scienceshttps://www.arontier.co/

Last Round

Strategic

Jul 2, 2024

Est. Valuation

$28.92M

Total Funding Raised

$3.62M

Company Overview

Arontier is a biotechnology company that develops an AI-driven drug discovery platform for the creation of antibodies, protein binders, and small-molecule drugs to treat incurable and rare diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

drug discoveryAI drug discoveryin silico drug discoveryantibody designprecision medicinesmall molecule designprotein designcomputational biologybioinformaticsneoantigen vaccinebiotech R&Dmultiomicsbiomarker discoveryAI biotechpharma tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arontier Comparables

Compare Arontier with similar companies based on industry and business-model similarity.

Arontier comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DR.NOAH Biotech
85%
Standigm
83%
HITS Inc.
82%

Arontier Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicJul 2, 2024
Series BDec 1, 2021
Series ANov 1, 2020

Arontier Investors

Notable investors and investment history

Arontier investors
InvestorRounds
Harang Technology InvestmentSeries B
HLB InvestmentStrategic
Mirae Asset Venture InvestmentSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors increased 36% MoM.

  • Mar 5, 2026

    Monthly visitors increased 74% MoM.

Arontier Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Arontier Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Arontier's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Employee Range15
Year Founded2017
Last FundingJul 2, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?